SEC Form 4 · accession 0001104659-15-075341
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Guyer
Officer — Chief Executive Officer · Director
Period of report
Oct 30, 2015
Accepted (ET)
Nov 3, 2015 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 30, 2015 | M | 18,582 | $10.03 | A | 48,492 | D | |
| Common StockF2 | Oct 30, 2015 | S | 18,482 | $49.88 | D | 30,010 | D | |
| Common Stock | Oct 30, 2015 | S | 100 | $50.27 | D | 29,910 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F3 | $10.03 | Oct 30, 2015 | M | 18,582 | A | — | Apr 25, 2023 | Common Stock | 18,582 | 224,666 | D |
Explanation of responses
- F1The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013.
- F2These shares were disposed of in multiple transactions on October 30, 2015 at actual sales prices ranging from $49.27 to $50.24 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.